Diabetes Drug May Slow Parkinson’s Disease
Exenatide was studied in a randomized, double blind, placebo controlled study. The drug is a glucagon like peptide 1(GLP-1) receptor agonist which improved off time and benefits persisted weeks [...]
Serotonin Loss May Drive Cognitive Decline
Studies have shown with normal aging and Alzheimer’s disease (AD) that serotonin degeneration occurs. The new study suggests that the serotonin system is affected in mild cognitive [...]
